drugset / Trial / NCT06120842
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This trial is a randomized study to evaluate and compare two doses of the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Timeline
- Start
- 2023-10-13
- Primary completion
- 2025-01-31
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | — | — |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |